Summary
Superconducting quantum bits, or qubits, use circuits made from superconducting materials to harness quantum mechanical states. These devices contain many atoms, but can behave as simple, controllable qubits. We are building technologies for the control and measurement of superconducting qubits to enable the first demonstration of an extensible, medium-scale quantum processor. Our approach includes the development of multilayer architectures where qubit and wiring circuitry are fabricated on different chips that are bonded together by means of thermocompression bonding technologies. This will make it possible to address qubits on a two-dimensional lattice on the order of 100 qubits. Implementing a two-dimensional array of superconducting qubits will allow for the realization of quantum-error correction, a critical step on the way to a fully scalable architecture. Through this work we also hope to study the loss mechanisms that limit the coherence time of superconducting qubits.

Figure 1. Two chips bonded with indium forming a tunnel for superconducting qubits (credit C.R.H. McRae and M. Mariantoni 2017).
Related Content

Harnessing the Promise of Quantum Materials for Future Electronic Devices
Summary Two-dimensional (2D) quantum materials, such as graphene and molybdenum disulfide, have great potential for use in future flexible and wearable electronics applications. With traditional silicon-based electronics nearing their theoretical performance limits, nano-electronics made from 2D quantum materials offer breakthrough opportunities for energy-efficient, wearable ubiquitous computation. In this project, we will study integration of […]
June 14, 2018

Quantum Computational Resources in the Presence of Symmetry
Summary Fault-tolerance is essential to the performance of quantum technologies, but known schemes are extremely resource intensive. Thus, improving existing schemes or inventing new schemes is of central importance. This joint project is based on the realization that fault-tolerance schemes make use of symmetries in fundamental ways, and that studying the problem of fault tolerance […]
March 13, 2019

Repurposing potential drug candidates for the treatment of COVID-19
Summary The main protease (Mpro) in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease (COVID-19), has emerged as a promising drug target. The scientific community has produced a large number of crystallographic structures of the protease, which mediates viral replication and transcription. These structures report several fragments with varied chemotypes […]
May 6, 2020